reglab/housing_qa huggingface dataset:
IA Code § 124B.1 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124B - PRECURSOR SUBSTANCES|Section 124B.1 - Definitions.

124B.1 Definitions.   As used in this chapter, unless the context otherwise requires:   1. “Board” means the board of pharmacy.   2. “Controlled substance” means a controlled substance as defined in section 124.101.   3. “Practitioner” means a practitioner as defined in section 155A.3.   4. “Precursor substance” means a substance which may be used as a precursor in the illegal production of a controlled substance and is specified under section 124B.2.   5. “Recipient” means a person in this state who purchases, transfers, or otherwise receives a precursor substance.   6. “Vendor” means a person who manufactures, wholesales, retails, or otherwise sells, transfers, or furnishes in this state a precursor substance.  90 Acts, ch 1251, §10  C91, §204B.1  C93, §124B.1  2007 Acts, ch 10, §16
IA Code § 124B.2 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124B - PRECURSOR SUBSTANCES|Section 124B.2 - Reporting required.

124B.2 Reporting required.   1. Effective July 1, 1990, a report to the board shall be submitted in accordance with this chapter by a manufacturer, retailer, or other person who sells, transfers, or otherwise furnishes to any person in this state any of the following substances:   a. Anthranilic acid, its esters, and its salts.   b. Benzyl cyanide.   c. Ethylamine and its salts.   d. Ergonovine and its salts.   e. Ergotamine and its salts.   f. 3,4 - methylenedioxyphenyl-2-propanone.   g. N-acetylanthranilic acid, its esters, and its salts.   h. Norpseudoephedrine, its salts, optical isomers, and salts of optical isomers.   i. Phenylacetic acid, its esters, and its salts.   j. Piperidine and its salts.   k. Methylamine and its salts.   l. Propionic anhydride.   m. Isosafrole.   n. Safrole.   o. Piperonal.   p. N-methylephedrine, its salts, optical isomers, and salts of optical isomers.   q. N-methylpseudoephedrine, its salts, optical isomers, and salts of optical isomers.   r. Hydriodic acid.   s. Benzaldehyde.   t. Nitroethane.   u. Gamma-Butyrolactone (also known as GBL; Dihydro-2(3H)-furanone; 1,2-Butanolide;   1,4-Butanolide; 4-Hydroxybutanoic acid lactone; or gamma-hydroxy-butyric acid lactone).   v. Red phosphorus.   w. White phosphorus (another name: yellow phosphorus).   x. Hypophosphorous acid and its salts (including ammonium hypophosphite, calcium hypophosphite, iron hypophosphite, potassium hypophosphite, manganese hypophosphite, magnesium hypophosphite, and sodium hypophosphite).   y. Iodine.   z. N-phenethyl-4-piperidone (NPP).   aa. Ergocristine and its salts.   ab. Alpha-phenylacetoacetonitrile and its salts, optical isomers, and salts of optical isomers. Other name: APAAN.   2. The board shall administer the regulatory provisions of this chapter and may, by rule adopted pursuant to chapter 17A, add a substance to or remove a substance from the list in subsection 1. In determining whether to add or remove a substance from the list, the board shall consider the following:   a. The likelihood that the substance may be used as a precursor in the illegal production of a controlled substance.   b. The availability of the substance.   c. The appropriateness of including the substance under this chapter or under chapter 124.   d. The extent and nature of legitimate uses for the substance.   3. On or before November 1 of each year, the board shall inform the general assembly of any substances added, deleted, or changed in the list contained in this section and shall provide an explanation of any addition, deletion, or change.  90 Acts, ch 1251, §11  C91, §204B.2  C93, §124B.2  2000 Acts, ch 1140, §17, 18; 2002 Acts, ch 1108, §2, 3; 2003 Acts, ch 53, §10; 2008 Acts, ch 1010, §5; 2009 Acts, ch 36, §1; 2012 Acts, ch 1122, §6; 2018 Acts, ch 1138, §30, 31  Referred to in §124B.1, 124B.3, 124B.6
IA Code § 124B.3 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124B - PRECURSOR SUBSTANCES|Section 124B.3 - Identification required.

124B.3 Identification required.   1. Before selling, transferring, or otherwise furnishing any substance specified in section 124B.2 to a person in this state, a vendor shall require proper identification from the purchaser.   2. For the purposes of this section, in the case of a face-to-face purchase, “proper identification” means all of the following:   a. A driver’s license containing the purchaser’s photograph and residential or mailing address, other than a post office box number, or any other official state-issued identification containing this information.   b. The motor vehicle license number of the vehicle owned or operated by the purchaser.   c. A letter of authorization from the person who is making the purchase. The letter shall include the person’s business license number and business address, a description as to how the substance will be used, and the purchaser’s signature. The vendor shall affix the vendor’s signature as a witness to the signature and identification of the purchaser.   3. The board shall provide by rule for the form of proper identification required for purchases which are not face to face.   4. A person who violates this section or rules adopted pursuant to this section commits a simple misdemeanor.  90 Acts, ch 1251, §12  C91, §204B.3  92 Acts, ch 1175, §27  C93, §124B.3  98 Acts, ch 1073, §9  Referred to in §124B.4, 124B.6
IA Code § 124B.4 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124B - PRECURSOR SUBSTANCES|Section 124B.4 - Vendor reporting.

124B.4 Vendor reporting.   1. At least twenty-one days prior to the delivery of a precursor substance to a recipient, the vendor shall submit a report of the transaction to the board. The report must contain the identification information specified under section 124B.3. However, if regular, repeated transactions of a particular precursor substance occur between the vendor and the recipient, the board may authorize the vendor to report the transactions monthly if either of the following conditions exists:   a. A pattern of regular supply of the precursor substance exists between the vendor and the recipient.   b. The recipient has established a record of lawfully using the precursor substance.   2. A vendor who does not submit a report pursuant to this section commits a serious misdemeanor.  90 Acts, ch 1251, §13  C91, §204B.4  C93, §124B.4  Referred to in §124B.6
IA Code § 124B.5 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124B - PRECURSOR SUBSTANCES|Section 124B.5 - Receipt of substance from outside the state — penalty.

124B.5 Receipt of substance from outside the state — penalty.   1. A vendor, recipient, or other person required to report pursuant to this chapter who receives a precursor substance from a source outside the state shall submit a report to the board pursuant to rules adopted by the board.   2. A person who does not submit a report required under this section commits a serious misdemeanor.  90 Acts, ch 1251, §14  C91, §204B.5  C93, §124B.5  Referred to in §124B.6
IA Code § 124B.6 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124B - PRECURSOR SUBSTANCES|Section 124B.6 - Exceptions.

124B.6 Exceptions.   The requirements of sections 124B.2 through 124B.5 do not apply to any of the following:   1. A licensed pharmacist or other person authorized under chapter 155A to sell or furnish a precursor substance upon the prescription of a practitioner.   2. A practitioner who administers or furnishes a precursor substance to a patient.   3. A vendor who holds a permit issued by the board and who sells, transfers, or otherwise furnishes a precursor substance to a practitioner or a pharmacy as defined in section 155A.3.   4. A sale, transfer, furnishing, or receipt of a drug containing ephedrine, phenylpropanolamine, or pseudoephedrine or of a cosmetic containing a precursor substance if the drug or cosmetic is lawfully sold, transferred, or furnished over the counter without a prescription in accordance with chapter 126.  90 Acts, ch 1251, §15  C91, §204B.6  C93, §124B.6  Referred to in §124B.8
IA Code § 124B.7 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124B - PRECURSOR SUBSTANCES|Section 124B.7 - Reporting form.

124B.7 Reporting form.   1. The board shall adopt rules prescribing a common form for the filing of reports required under this chapter. The rules shall provide that the information which must be submitted shall include but is not limited to all of the following:   a. The name of the precursor substance.   b. The quantity of the precursor substance sold, transferred, or furnished.   c. The date the precursor substance was sold, transferred, or furnished.   d. The name and address of the recipient.   e. The name and address of the vendor.   2. Reports authorized under subsection 1 may be computer-generated and submitted monthly in accordance with rules adopted by the board.  90 Acts, ch 1251, §16  C91, §204B.7  C93, §124B.7
IA Code § 124B.8 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124B - PRECURSOR SUBSTANCES|Section 124B.8 - Missing quantity — reporting.

124B.8 Missing quantity — reporting.   A person who is required to report to the board pursuant to this chapter or a person listed as an exception under section 124B.6 shall report to the board either of the following occurrences within seven days of knowledge of the loss or occurrence:   1. Loss or theft of a precursor substance.   2. A difference between the amount of a precursor substance shipped and the amount of a precursor substance received. If applicable, the report shall include the name of the person who transported the precursor substance and the date of shipment.  90 Acts, ch 1251, §17  C91, §204B.8  C93, §124B.8
IA Code § 124B.9 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124B - PRECURSOR SUBSTANCES|Section 124B.9 - Sale, transfer, furnishing, or receipt for unlawful purpose — penalty.

124B.9 Sale, transfer, furnishing, or receipt for unlawful purpose — penalty.   1. A person who sells, transfers, or otherwise furnishes a precursor substance with knowledge or the intent that the recipient will use the precursor substance to unlawfully manufacture a controlled substance commits a class “C” felony.   2. A person who receives a precursor substance with the intent that the substance be used unlawfully to manufacture a controlled substance commits a class “C” felony.  90 Acts, ch 1251, §18  C91, §204B.9  C93, §124B.9  2004 Acts, ch 1057, §2  Unlawful manufacture of a controlled substance, see §124.401
IA Code § 124B.10 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124B - PRECURSOR SUBSTANCES|Section 124B.10 - False statement — penalty.

124B.10 False statement — penalty.   A person who knowingly makes a false statement in connection with any report or record required to be made under this chapter commits an aggravated misdemeanor.  90 Acts, ch 1251, §19  C91, §204B.10  C93, §124B.10
IA Code § 124B.11 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124B - PRECURSOR SUBSTANCES|Section 124B.11 - Permit requirements — penalty.

124B.11 Permit requirements — penalty.   1. A vendor or a recipient who receives a precursor substance from a source outside the state shall obtain a permit for the transaction from the board. However, a permit is not required of a vendor of a drug containing ephedrine, phenylpropanolamine, or pseudoephedrine or of a cosmetic that contains a precursor substance if the drug or cosmetic is lawfully sold, transferred, or furnished either over the counter without a prescription in accordance with chapter 126 or with a prescription pursuant to chapter 155A.   2. An application for a permit shall be filed in writing and signed by the applicant, and shall set forth the name of the applicant, the business in which the applicant is engaged, the business address of the applicant, and a full description of any precursor substance sold, transferred, or otherwise furnished or received.   3. The board may grant a permit on a form adopted by rule. A permit shall be effective for not more than one year from the date of issuance.   4. An applicant shall pay, at the time of filing an application, a permit fee determined by the board.   5. A permit granted under this chapter may be annually renewed on a date to be determined by the board pursuant to rule, upon the filing of a renewal application and the payment of a permit renewal fee.   6. Permit fees charged by the board shall not exceed the costs incurred by the board in administering this chapter.   7. Selling, transferring, or otherwise furnishing, or receiving a precursor substance without a permit obtained pursuant to this section is a serious misdemeanor.  90 Acts, ch 1251, §20  C91, §204B.11  C93, §124B.11
IA Code § 124B.12 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124B - PRECURSOR SUBSTANCES|Section 124B.12 - Permit — refusal, suspension, or revocation.

124B.12 Permit — refusal, suspension, or revocation.   The board shall refuse, suspend, or revoke a permit upon finding that any of the following conditions exist:   1. The permit was obtained through fraud, misrepresentation, or deceit.   2. The permittee has violated or has permitted any employee of the permittee to violate any of the laws of this state relating to drugs, controlled substances, cosmetics, or nonprescription drugs, or has violated this chapter, a rule adopted pursuant to this chapter, or any other rule of the board.  90 Acts, ch 1251, §21  C91, §204B.12  C93, §124B.12
IA Code § 124C.1 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124C - CLEANUP OF CLANDESTINE LABORATORY SITES|Section 124C.1 - Definitions.

124C.1 Definitions.   As used in this chapter, unless the context clearly requires otherwise:   1. “Clandestine laboratory site” means a location or operation, including but not limited to buildings or vehicles equipped with glassware, heating devices, and precursors or related reagents and solvents needed to unlawfully prepare or manufacture controlled substances defined in chapter 124.   2. “Cleanup” means actions necessary to contain, collect, control, identify, analyze, disassemble, treat, remove, or otherwise disperse all substances and materials, including but not limited to those found to be hazardous waste as defined in section 455B.411 and controlled substances defined in chapter 124, including contamination caused by those chemicals or substances.   3. “Commissioner” means the commissioner of public safety.   4. “Department” means the department of public safety.   5. “Hazardous substance” means any substance or mixture of substances that presents a danger to the public health or safety and includes, but is not limited to, a substance that is toxic, corrosive, or flammable, and other substances defined in rules adopted pursuant to section 455B.381 and controlled substances as defined in chapter 124.   6. “Person having control over a clandestine laboratory site” means a person who at any time possesses, produces, handles, stores, uses, transports, or disposes of a hazardous substance or controlled substance used or intended for use at a clandestine laboratory site. A person having control over a clandestine laboratory site does not include persons performing duties listed in section 124C.2 at the direction of the commissioner and does not include a person who is the owner of the property or a person holding a security interest in the property in or upon which the clandestine laboratory site is located unless the person knew that a clandestine laboratory existed in or upon the person’s property.  93 Acts, ch 141, §1; 2000 Acts, ch 1148, §1; 2002 Acts, ch 1119, §12, 200, 201; 2003 Acts, ch 44, §35
IA Code § 124C.2 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124C - CLEANUP OF CLANDESTINE LABORATORY SITES|Section 124C.2 - Powers and duties of the commissioner.

124C.2 Powers and duties of the commissioner.   1. The commissioner or the commissioner’s designee may use funds appropriated or otherwise available to the department for the following purposes:   a. Administrative services for the identification, assessment, and cleanup of clandestine laboratory sites.   b. Payments to other government agencies or private contractors for services consistent with the management and cleanup of a clandestine laboratory site.   c. Emergency response activities involving clandestine laboratory sites, including surveillance, entry, security, cleanup, and disposal.   2. The commissioner may request the assistance of other state, federal, and local agencies as necessary.   3. The commissioner shall proceed, pursuant to this section, to collect all costs incurred in cleanup of a clandestine laboratory site from the person having control over a clandestine laboratory site.   4. The commissioner shall make all reasonable efforts to recover the full amount of moneys expended, through litigation or otherwise. Moneys recovered shall be deposited with the treasurer of state and credited to the department of public safety.  93 Acts, ch 141, §2; 2009 Acts, ch 41, §184  Referred to in §124C.1
IA Code § 124C.3 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124C - CLEANUP OF CLANDESTINE LABORATORY SITES|Section 124C.3 - Liability to the state.

124C.3 Liability to the state.   A person having control over a clandestine laboratory site shall be strictly liable to the state for all of the following:   1. The reasonable costs incurred by the state as a result of cleanup of the site.   2. The reasonable costs incurred by the state to evacuate people from the area threatened by the clandestine laboratory site.   3. The reasonable damages to the state for the injury to, destruction of, or loss of natural resources resulting from the clandestine laboratory site, including the costs of assessing the injury, destruction, or loss.  93 Acts, ch 141, §3  Referred to in §124C.4
IA Code § 124C.4 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124C - CLEANUP OF CLANDESTINE LABORATORY SITES|Section 124C.4 - Claim of state.

124C.4 Claim of state.   1. An amount for which a person having control over a clandestine laboratory is liable to the state shall constitute a lien in favor of the state upon all property and rights to property, real and personal, belonging to that person. This lien shall attach at the time the charges set out in section 124C.3 become due and payable and shall continue for ten years from the time the lien attaches unless sooner released or otherwise discharged. The lien may be extended, within ten years from the date the lien attaches, by filing a notice with the appropriate county official of the appropriate county and from the time of filing the lien shall be extended as to the property in that county for ten years, unless sooner released or otherwise discharged, with no limit on the number of extensions.   2. In order to preserve the lien against subsequent mortgagees, purchasers, or judgment creditors for value and without notice of the lien, the commissioner shall file with the recorder of the county in which the property is located a notice of the lien. A laboratory cleanup lien shall be recorded in the index of income tax liens in the county.   3. Each notice of lien shall be endorsed with the day, hour, and minute when the notice was filed for recording and the document reference number, and the notice shall be preserved, indexed, and recorded in the manner provided for recording real estate mortgages. The lien is effective from the time of its indexing. The department shall pay recording fees as provided by section 331.604 for the recording of the lien or for its satisfaction.   4. Upon payment of a charge for which the commissioner has filed a notice of lien with a county, the commissioner shall immediately file with the county a satisfaction of the charge and the satisfaction of the charge shall be indicated on the index.   5. The attorney general, upon the request of the commissioner, shall bring an action at law or in equity, without bond, to enforce payment of any charges or penalties, and in such action the attorney general shall have the assistance of the county attorney of the county in which the action is pending.   6. The remedies available to the state in this chapter shall be cumulative and no action taken by the commissioner or attorney general shall be construed to be an election on the part of the state to pursue any remedy to the exclusion of any other remedy provided by law.  93 Acts, ch 141, §4; 2002 Acts, ch 1113, §2; 2009 Acts, ch 27, §3; 2009 Acts, ch 41, §185
IA Code § 124C.5 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124C - CLEANUP OF CLANDESTINE LABORATORY SITES|Section 124C.5 - Liability of state employees or persons providing cleanup assistance.

124C.5 Liability of state employees or persons providing cleanup assistance.   The state and its officers or employees are not liable for damages or injury caused by a condition at a clandestine laboratory site or resulting from action or inaction taken by any officers or employees when acting in their official capacity pursuant to this chapter, unless the damage or injury resulted from intentional wrongdoing or gross negligence.  93 Acts, ch 141, §5
IA Code § 124C.6 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124C - CLEANUP OF CLANDESTINE LABORATORY SITES|Section 124C.6 - Legal remedies.

124C.6 Legal remedies.   This chapter does not deny a person any legal or equitable rights, remedies, or defenses, or affect any legal relationship other than the legal relationship between the state and a person having control over a clandestine laboratory site.  93 Acts, ch 141, §6
IA Code § 124C.7 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124C - CLEANUP OF CLANDESTINE LABORATORY SITES|Section 124C.7 - Rulemaking authority.

124C.7 Rulemaking authority.   The department may adopt rules pursuant to chapter 17A necessary to administer this chapter.  93 Acts, ch 141, §7
IA Code § 124E.1 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124E - MEDICAL CANNABIDIOL ACT|Section 124E.1 - Short title.

124E.1 Short title.   This chapter shall be known and may be cited as the “Medical Cannabidiol Act”.  2017 Acts, ch 162, §4, 25
IA Code § 124E.3 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124E - MEDICAL CANNABIDIOL ACT|Section 124E.3 - Health care practitioner certification — duties.

124E.3 Health care practitioner certification — duties.   1. Prior to a patient’s submission of an application for a medical cannabidiol registration card pursuant to section 124E.4, a health care practitioner shall do all of the following:   a. Determine, in the health care practitioner’s medical judgment, whether the patient whom the health care practitioner has examined and treated suffers from a debilitating medical condition that qualifies for the use of medical cannabidiol under this chapter, and if so determined, provide the patient with a written certification of that diagnosis.   b. Provide explanatory information as provided by the department to the patient about the therapeutic use of medical cannabidiol and the possible risks, benefits, and side effects of the proposed treatment.   2. Subsequently, the health care practitioner shall do the following:   a. Determine, on an annual basis, if the patient continues to suffer from a debilitating medical condition and, if so, issue the patient a new certification of that diagnosis.   b. Otherwise comply with all requirements established by the department pursuant to rule.   3. A health care practitioner may provide, but has no duty to provide, a written certification pursuant to this section.  2017 Acts, ch 162, §6, 25  Referred to in §124E.11